Clinical Perinatal Software Market Analysis

Clinical Perinatal Software Market Analysis

The market by product type is bifurcated into integrated and standalone. The integrated segment dominated the market with a revenue of USD 168 million in 2023.

• The integrated segment is expected to expand rapidly due to increased demand among medical professionals for continuous workflow integration. Technological developments coupled with electronic health records (EHR), billing systems, picture archiving and communication systems (PACS), as well as the implementation of artificial intelligence and data analytics in the system, are likely to fuel segmental growth.
   
• Furthermore, improved capabilities of clinical perinatal software have resulted in more accurate predictions and individualized treatment plans, increasing its use in maternity care. For example, in January 2024, Pediatrix Medical Group, a US maternity care provider, announced the adoption of Sonio, a cloud-based, AI-powered prenatal care reporting and picture management service. This innovative technology streamlines workflow while improving quality assurance and clinical results, resulting in a better experience for both patients and doctors. As a result of the factors described above, the integrated segment is predicted to increase significantly throughout the forecast period.
   
• Furthermore, rising government funding for novel models combined with community-based maternal care services makes a significant contribution to segmental growth. In September 2023, the US Department of Health and Human Services (HHS) announced that 11 groups had received more than USD 13 million in funds for its Healthy Families Community-Based Perinatal Health Initiative (COPHI). Its goal is to enhance maternity support services for pregnant and postpartum mothers. Such initiatives promote the use of clinical perinatal software, which influences segmental growth.
   

Based on deployment mode, the clinical perinatal software market is bifurcated into on-premises and cloud-based. The on-premises segment dominates the market and is expected to grow at an 9.3% CAGR during the forecast period.
 

• One of the primary factors is the heightened concern for data security and privacy. Healthcare institutions often prefer on-premises solutions because they provide direct control over sensitive patient data, aligning with stringent regulatory requirements like the Health Insurance Portability and Accountability Act (HIPAA). This control is particularly crucial for clinical perinatal software, which handles sensitive data related to maternal and neonatal care.
   
• Additionally, the on-premises model allows for greater customization and integration with existing hospital systems. Healthcare providers can tailor the software to meet specific organizational needs, workflows, and compliance standards. This flexibility ensures that the software can be seamlessly incorporated into the broader hospital information system without disrupting existing processes.
   

Based on application, the clinical perinatal software market is divided into fetal monitor data services, workflow management, and patient documentation. The fetal monitor data services dominated the market in 2023 and held a market share of 43.1% in 2023.
 

• The increasing awareness and emphasis on fetal health and early detection of potential complications during pregnancy significantly drive the demand for advanced fetal monitoring solutions. These services provide real-time tracking and analysis of fetal heart rate, movements, and contractions, enabling healthcare providers to make informed decisions and intervene promptly if abnormalities are detected.
   
• Technological advancements in fetal monitoring devices, such as wireless and portable monitors, have enhanced the usability and accessibility of fetal monitor data services. These innovations allow for continuous and non-invasive monitoring of the fetus, even in remote or low-resource settings, contributing to their widespread adoption.
   
• Moreover, the integration of artificial intelligence in healthcare and machine learning (ML) in fetal monitor data services has improved the accuracy and predictive capabilities of these systems. AI-driven analytics can identify patterns and potential risks, allowing for proactive management of the pregnancy and reducing the chances of adverse outcomes.
   

The clinical perinatal software market by end-use is segmented into hospitals and maternity clinics. The hospitals segment dominated the market in 2023 and is predicted to rise rapidly during the forecast period.
 

• The demand for integrated healthcare solutions in perinatal care is critical. Hospitals need robust software that seamlessly integrates with existing Hospital Information Systems (HIS) and Electronic Health Records (EHR). Such a unified platform is essential for managing patient data efficiently and streamlining workflows across departments.
   
• Hospitals often manage high-risk pregnancies and complex perinatal cases, requiring sophisticated monitoring and decision-support tools. Clinical perinatal software offers real-time data analysis, predictive insights, and customized care plans, which are vital for improving maternal and fetal outcomes and minimizing complications.
   
• Hospitals possess the resources and infrastructure necessary for the deployment and maintenance of comprehensive perinatal software systems. This capability ensures the functionality and reliability of these systems, making hospitals ideal for adopting such technologies. Moreover, as hospitals aim to meet regulatory compliance and accreditation standards, the use of standardized and effective monitoring and documentation systems in perinatal care becomes increasingly important.
   

North America clinical perinatal software market accounted for USD 103.7 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

• Factors such as well-structured and established healthcare systems, as well as high healthcare expenditures, are expected to promote regional market expansion. According to figures given by the Centers for Medicare & Medicaid Services (CMS), healthcare spending in the U.S. is expected to reach over USD 7.2 trillion, or nearly 20.0% of GDP by 2031. As a result, North America is likely to account for a significant portion of the market.
   
• The region's perinatal birth rates are influenced by a variety of biological and environmental factors, including maternal age, smoking habits, obesity, genito-urinary infection, diabetes mellitus, hypertension, alcohol and illegal drug usage. According to March of Dimes data, perinatal birth rates in the U.S. were highest for women aged 40 and older between 2020 and 2022, compared to those under 40. Furthermore, the Ontario Fetal Centre reports that almost 8.0% of newborns (or around 25,000) are born preterm in Canada each year.
   
• According to the March of Dimes, 13.4% and 12.8% of women of reproductive age reported smoking in Mexico and the U.S., respectively, in 2022. Smoking has long-term health consequences and is a major risk factor for premature birth. The increase in preterm births is expected to fuel demand for perinatal software, as preterm babies are more vulnerable to the conditions listed above. As a result of the aforementioned factors, the market under consideration is predicted to grow significantly in the region over the forecast period.